Horizon Technology Finance upgraded by Compass Point with a new price target
$HRZN
Finance: Consumer Services
Finance
Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/17/2024 | $8.25 | Sell → Neutral | Compass Point |
| 2/28/2024 | Buy → Neutral | Ladenburg Thalmann | |
| 1/8/2024 | $11.00 | Neutral → Sell | B. Riley Securities |
| 10/17/2023 | $10.00 | Neutral → Sell | Compass Point |
| 9/27/2023 | $11.00 → $10.50 | Sell → Neutral | Compass Point |
| 8/4/2023 | $11.00 | Neutral → Sell | Compass Point |
| 4/11/2023 | $12.50 | Buy | Ladenburg Thalmann |
| 12/20/2022 | $11.50 → $10.50 | Mkt Perform → Underperform | Keefe Bruyette |
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
DEFA14A - Horizon Technology Finance Corp (0001487428) (Filer)
DEFA14A - Horizon Technology Finance Corp (0001487428) (Filer)
- HRZN Originates $59.1 Million of New Loans in Q4 - - HRZN Ends Year with Committed Backlog of $206.5 Million - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today provided its portfolio update for the fourth quarter ended December 31, 2024 and an update on the lending platform ("Horizon Platform") of Horizon Technology Finance Management LLC ("HTFM"), its investment adviser. "We had a strong close to
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $35 million venture loan facility to Onkos Surgical ("Onkos"), of which $30 million has been initially funded. Onkos intends to use the proceeds of the loan facility to accelerate manufacturing and commercialization of NanoCept™, a groundbreaking, antibacterial coating technology that is used on FDA-granted orthopaedic
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced it has provided a $10 million venture loan facility to OneNetwork, Inc. dba Finexio, of which $5 million has been initially funded. Finexio, a leader in the B2B payments industry, delivers "Accounts Payable (AP) Payments as a Service", a fully-managed AP payments solution that leverages AI to optimize, monetize, and secure the entire pa
Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25
Ladenburg Thalmann downgraded Horizon Technology Finance from Buy to Neutral
B. Riley Securities downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $11.00
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr
FARMINGTON, Conn., June 9, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon," or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that it has appointed Daniel S. Devorsetz as Chief Operating Officer effective immediately. In addition, Devorsetz has concurrently been appointed as Chief Operating Officer of Horizon's external investment advisor, Horizon Technology Finance Management LLC (the "Advisor" or "HTFM"). He currently serves as Chief Investment Of
- Third Quarter 2024 Net Investment Income per Share of $0.32; NAV per Share of $9.06 - - Debt Portfolio Yield of 15.9% - - HRZN Ends Quarter with Committed Backlog of $190 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through March 2025 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the third quarter ended September 30, 20
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the third quarter ended September 30, 2024 on Tuesday, October 29, 2024, after the close of market trading. The Company has scheduled a conference call to discuss the results on Wednesday, October 30, 2024, at 9:00 a.m. ET. The conference call will feature remarks by Robert D. Pomeroy, Jr., C
- Second Quarter 2024 Net Investment Income per Share of $0.36; NAV per Share of $9.12 - - Debt Portfolio Yield of 15.9% - - HRZN Ends Quarter with Committed Backlog of $138 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through December 2024 - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital-backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced its financial results for the second quarter ended June 30